To control the quality of circulated medicines intended for medical purposes, to protect the legal turnover from falsified, counterfeit, and poor-quality drugs and in order to implement the clause of the relevant presidential instructions of February 20, 2015, amendments are introduced to the Federal Law On the Circulation of Medicinal Drugs, pursuant to which a federal state information system shall be created to monitor the movement of medicines intended for medical purposes from the point of production to the final user, with means of identification to be used with regard to the medicinal drugs.
Documents
Amendments to Law on Circulation of Medicinal Drugs
Vladimir Putin signed the Federal Law On Amending the Federal Law On the Circulation of Medicinal Drugs.